Page last updated: 2024-09-03

ta 993 and fura-2

ta 993 has been researched along with fura-2 in 1 studies

Compound Research Comparison

Studies (ta 993)	Trials (ta 993)	Recent Studies (post-2010) (ta 993)	Studies (fura-2)	Trials (fura-2)	Recent Studies (post-2010) (fura-2)
10	0	0	4,362	12	291

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doi, H; Ikeo, T; Karasawa, T; Katoh, M; Narita, H; Odawara, A; Takagi, M	1

Other Studies

1 other study(ies) available for ta 993 and fura-2

Article	Year
Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation. European journal of pharmacology, 2000, Jul-07, Volume: 399, Issue:2-3 Topics: Actins; Adenosine Diphosphate; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diltiazem; Dose-Response Relationship, Drug; Fibrinogen; Fura-2; Humans; Male; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding	2000

Article

Year

Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation.

European journal of pharmacology, 2000, Jul-07, Volume: 399, Issue:2-3

Topics: Actins; Adenosine Diphosphate; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diltiazem; Dose-Response Relationship, Drug; Fibrinogen; Fura-2; Humans; Male; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding

2000